THC Therapeutics (THC Therapeutics) Scaled Net Operating Assets

: -198.31 (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

THC Therapeutics's operating assets for the quarter that ended in Jul. 2023 was $0.01 Mil. THC Therapeutics's operating liabilities for the quarter that ended in Jul. 2023 was $2.59 Mil. THC Therapeutics's Total Assets for the quarter that ended in Apr. 2023 was $0.01 Mil. Therefore, THC Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Jul. 2023 was -198.31.

THC Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for THC Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Scaled Net Operating Assets

-0.35

-2.61

-23.67

-4.81

-12.45

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Scaled Net Operating Assets																-10.74	-21.72	-46.46	-110.65	-198.31

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Therapeutics Scaled Net Operating Assets Distribution

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Scaled Net Operating Assets falls into.

THC Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

THC Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2023 )
=	(Operating Assets (A: Jul. 2023 )	-	Operating Liabilities (A: Jul. 2023 ))	/	Total Assets (A: Jul. 2022 )
=	(0.013	-	2.591)	/	0.207
=	-12.45

where

	Operating Assets		(A: Jul. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.013	-	0
=	0.013

	Operating Liabilities		(A: Jul. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.323	-	0	-	0.732
=	2.591

THC Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jul. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jul. 2023 )
=	(Operating Assets (Q: Jul. 2023 )	-	Operating Liabilities (Q: Jul. 2023 ))	/	Total Assets (Q: Apr. 2023 )
=	(0.013	-	2.591)	/	0.013
=	-198.31

where

	Operating Assets		(Q: Jul. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.013	-	0
=	0.013

	Operating Liabilities		(Q: Jul. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.323	-	0	-	0.732
=	2.591

THC Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX